Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Claudia Zampaloni's publication output changed over time?
ScholarIQpublication output · 2003–2025
Output grew0% over the shown period — from 1 works in 2003 to 1 in 2025.
1
1
1
1
1
1
1
1
1
1
2003200420062008201720182019202020242025
What are the most-cited papers on Claudia Zampaloni?
ScholarIQmost cited works
A novel antibiotic class targeting the lipopolysaccharide transporter
Claudia Zampaloni, Patrizio Mattei, Konrad Bleicher, Lotte Winther, Claudia Thäte, Christian Bucher, Jean‐Michel Adam, Alexander Alanine, Kurt E. Amrein, Vadim Baidin, Christoph Bieniossek, Caterina Bissantz, Franziska Boess, Carina Cantrill, Thomas Clairfeuille, Fabian Dey, Patrick Di Giorgio, Pauline du Castel, David Dylus, Paweł Dżygiel, Antonio Felici, Fernando García-Alcalde, Andreas Haldimann, Matthew Leipner, Semen A. Leyn, Séverine Louvel, Pauline Misson, Andrei L. Osterman, Karanbir S. Pahil, S. Rigo, Adrian Schäublin, Sebastian Scharf, P Schmitz, Theodor Stoll, Andrej Trauner, Sannah Zoffmann, Daniel Kahne, John A. T. Young, Michael A. Lobritz, Kenneth A. Bradley
Nature. 2024296 CitationsOPEN ACCESS
Comparative evaluation of rRNA depletion procedures for the improved analysis of bacterial biofilm and mixed pathogen culture transcriptomes
Olga Petrova, Fernando García-Alcalde, Claudia Zampaloni, Karin Sauer
Scientific Reports. 201787 CitationsOPEN ACCESS
Biofilm Induced Tolerance towards Antimicrobial Peptides
Anders Folkesson, Janus A. J. Haagensen, Claudia Zampaloni, Claus Sternberg, Søren Molin
PLoS ONE. 200877 CitationsOPEN ACCESS
Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections
Dezemona Petrelli, Claudia Zampaloni, Simonetta D’Ercole, Manuela Prenna, Patrizia Ballarini, Sandro Ripa, Luca A. Vitali
S130127385. 200662 Citations
<i>In Vivo</i> Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
Marguerite L. Monogue, Sara Giovagnoli, Caterina Bissantz, Claudia Zampaloni, David P. Nicolau
Antimicrobial Agents and Chemotherapy. 201855 CitationsOPEN ACCESS
Related on ScholarIQ
Roche (Switzerland)
Institution
A novel antibiotic class targeting the lipopolysaccharide transporter
Paper
Comparative evaluation of rRNA depletion procedures for the improved analysis of bacterial biofilm and mixed pathogen culture transcriptomes
Paper
Biofilm Induced Tolerance towards Antimicrobial Peptides
Paper
Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections
Paper
<i>In Vivo</i> Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
Paper